Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
lidocaine hydrochloride + povidone-iodine + bupivacaine hydrochloride + triamcinolone
- Development stage
- Unknown
- Lead developer
- Asclemed USA
- Modality
- Small Molecules
- Administration
- Parenteral, Percutaneous
01
Overview
A multi-component pharmaceutical kit containing **lidocaine hydrochloride**, **bupivacaine hydrochloride**, **triamcinolone**, and **povidone-iodine** for local or regional anesthesia and analgesia. The two amide local anesthetics, lidocaine and bupivacaine, reduce nerve impulse initiation and conduction by blocking voltage-gated sodium channels in peripheral nerves, while triamcinolone provides local anti-inflammatory corticosteroid activity and povidone-iodine serves as an antiseptic for procedural site preparation. Publicly described examples include specialty kits such as P-CARE K80MX, P-CARE K40MX, and MLK F4 KIT; these appear to be marketed or compounded procedural kits rather than a single novel proprietary molecular entity, and the combination itself has been described in public drug-listing sources rather than as a standalone innovative development program.
- Brand names
- P-CARE K80MXP-CARE K40MXMLK F4 KIT
- Other names
- lidocaine hydrochloride + povidone-iodine + bupivacaine hydrochloride + triamcinolonelidocaine hydrochloride + povidone-iodine + bupivacaine hydrochloride + triamcinolone acetonide
02
Targets
GR (Glucocorticoid receptor)Kir (Inward-rectifier potassium channels)NaV (Voltage-gated sodium channels)
Beyond the preview
Go deeper on lidocaine hydrochloride + povidone-iodine + bupivacaine hydrochloride + triamcinolone.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on lidocaine hydrochloride + povidone-iodine + bupivacaine hydrochloride + triamcinolone.